{"id":"doi:10.1038/s41571-019-0175-7","kind":"review","title":"Regulatory T cells in cancer immunosuppression — implications for anticancer therapy","authors":["Yosuke Togashi","Kohei Shitara","Hiroyoshi Nishikawa"],"author_count":3,"year":2019,"published":"2019-01-31","venue":"Nature Reviews Clinical Oncology","cited_by":1555,"doi":"10.1038/s41571-019-0175-7","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41571-019-0175-7","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41571-019-0175-7","updated":null,"pmid":"30705439","pmcid":null,"openalex_id":"W2914396734","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["T-cell and B-cell Immunology"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}